In summary, the complicated metabolic, inflammatory, and hormone conditions of PCOS patients may alter SHBG regulation and disrupt the predictive role of SHBG concentrations in ovarian response during the COH cycle. This evidence concerns the gene SHBG and polycystic ovary syndrome.